학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 244건 | 목록 1~10
Academic Journal
Santagata S; Istituto Nazionale Tumori-IRCCS-Fondazione, Italy.; Trotta AM; NCI Pascale, Napoli, Italy.; D'Alterio C; Istituto Nazionale per lo Studio e la Cura dei Tumori, Napoli, Italy.; Napolitano M; NCI Pascale, Naples, Italy.; Rea G; Istituto Nazionale Tumori-IRCCS-Fondazione, Italy.; Di Napoli M; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Italy.; Portella L; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italy.; Ieranò C; Istituto Nazionale Tumori - IRCCS -Fondazione G. Pascale, Naples, Italy.; Guardascione G; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italy.; Coppola E; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Italy.; Caux C; Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Dubois B; CRCL, UMR INSERM 1052, CNRS 5286, Lyon, France.; Boyle HJ; Centre Léon Berard, LYON, France.; Carles J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rossetti S; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Italy.; Azzaro R; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Italy.; Feroce F; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Italy.; Perdonà S; Ist Nazionale dei Tumori, Naples, Italy.; Fordellone M; University of Campania 'Luigi Vanvitelli', Naples, Italy.; Bello AM; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Italy.; Califano D; Istituto Nazionale Tumori -IRCCS- Fondazione G. Pascale- Napoli, Italia, Naples, Italy.; Chiodini P; University of Campania 'Luigi Vanvitelli', Naples, Italy.; Pignata S; Istituto Nazionale per lo Studio e la Cura dei Tumori - IRCCS Fondazione G Pascale, Napoli, Italy.; Scala S; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italy.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Le Saux O; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France.; Ardin M; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Berthet J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Barrin S; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Bourhis M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Cinier J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lounici Y; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Treilleux I; Department of Anatomopathology, Centre Léon Bérard, 69008, Lyon, France.; Just PA; Department of Anatomopathology, AP-HM, Marseille, France.; Bataillon G; Department of Anatomopathology, University hospital of Toulouse, Toulouse, France.; Savoye AM; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Institut Jean Godinot, Reims, France.; Mouret-Reynier MA; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.; Coquan E; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre François Baclesse, Caen, France.; Derbel O; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon, France.; Jeay L; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France.; Bouizaguen S; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France.; Labidi-Galy I; Department of Oncology, Hôpitaux universitaires de Genève, Faculty of Medecine, Center of Translational Research in Onco-Hematology, Swiss Cancer Center Leman, Geneva, Switzerland.; Tabone-Eglinger S; Human Biological Resources, Centre Léon Bérard, 69008, Lyon, France.; Ferrari A; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France.; Thomas E; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France.; Ménétrier-Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Tartour E; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Galy-Fauroux I; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie, PSL Research University, 75005, Paris, France.; Terme M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Dubois B; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Ray-Coquard I; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France. isabelle.ray-coquard@lyon.unicancer.fr.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Dalle S; Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Verronese E; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; N'Kodia A; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Bardin C; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Rodriguez C; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Andrieu T; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Eberhardt A; Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Chemin G; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Hasan U; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Le-Bouar M; Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.; Caramel J; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Amini-Adle M; Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.; Bendriss-Vermare N; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Dubois B; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Caux C; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Ménétrier-Caux C; Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Lalle G; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Lautraite R; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Bouherrou K; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Plaschka M; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Pignata A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), UMR INSERM 1291, CNRS 5051, Université Toulouse III , Toulouse, France.; Voisin A; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Twardowski J; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Perrin-Niquet M; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Stéphan P; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Durget S; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Tonon L; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Ardin M; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Degletagne C; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Viari A; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Belgarbi Dutron L; Biology Department, Ecole Normale Supérieure of Lyon, Lyon, France.; Davoust N; Laboratory of Biology and Modelling of the Cell, Ecole Normale Supérieure of Lyon, CNRS UMR 5239, INSERM U1293 , Lyon, France.; Postler TS; Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Zhao J; Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Caux C; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Caramel J; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Dalle S; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Cassier PA; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.; Klein U; Division of Haematology and Immunology, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.; Schmidt-Supprian M; Institute of Experimental Hematology, School of Medicine, Technical University of Munich , Munich, Germany.; Center for Translational Cancer Research, School of Medicine, Technical University of Munich , Munich, Germany.; German Cancer Consortium and German Cancer Research Center , Heidelberg, Germany.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), UMR INSERM 1291, CNRS 5051, Université Toulouse III , Toulouse, France.; Ghosh S; Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Grinberg-Bleyer Y; Cancer Research Center of Lyon, Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1 , Lyon, France.
Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Academic Journal
Dougé A; Service d'oncologie médicale, centre hospitalier universitaire, Clermont-Ferrand, France; EA(UR)7453 CHELTER, université Clermont Auvergne, Clermont-Ferrand, France. Electronic address: adouge@chu-clermontferrand.fr.; Caux C; CNRS 5286, centre de recherche en cancérologie de Lyon, Inserm U1052, université Claude-Bernard Lyon 1, 69008 Lyon, France.; Bay JO; Service d'oncologie médicale, centre hospitalier universitaire, Clermont-Ferrand, France; EA(UR)7453 CHELTER, université Clermont Auvergne, Clermont-Ferrand, France.
Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE
Academic Journal
Voissière A; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Gomez-Roca C; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Chabaud S; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Rodriguez C; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Nkodia A; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Berthet J; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Montane L; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Bidaux AS; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Treilleux I; Biopathology Department, Centre Léon Bérard, Lyon, France.; Eberst L; Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, Lyon, France.; Terret C; Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, Lyon, France.; Korakis I; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Garin G; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Pérol D; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Delord JP; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Caux C; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Dubois B; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Ménétrier-Caux C; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Bendriss-Vermare N; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Cassier PA; Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, Lyon, France.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Coutant A; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Cockenpot V; Department of Pathology, Centre Léon Bérard, Lyon, France.; Muller L; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Degletagne C; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Pommier R; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Plateforme de bioinformatique Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.; Tonon L; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Plateforme de bioinformatique Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.; Ardin M; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Plateforme de bioinformatique Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.; Michallet MC; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Caux C; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Laurent M; Centre Léon Bérard, Lyon, France.; Morel AP; Centre Léon Bérard, Lyon, France.; Saintigny P; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Centre Léon Bérard, Lyon, France; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Puisieux A; Centre Léon Bérard, Lyon, France; Institut Curie, PSL Research University, Paris, France; Chemical Biology of Cancer Laboratory, CNRS UMR 3666, INSERM U1143, Paris, France.; Ouzounova M; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France. Electronic address: maria.ouzounova@lyon.unicancer.fr.; Martinez P; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France. Electronic address: pierre.martinez@lyon.unicancer.fr.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE
Academic Journal
Di Roio A; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Hubert M; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Besson L; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Bossennec M; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Rodriguez C; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Grinberg-Bleyer Y; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Lalle G; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Moudombi L; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Schneider R; Plateforme Gilles Thomas, Centre de Recherche en cancérologie de Lyon, Lyon, France.; Degletagne C; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Treilleux I; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; BioPathology Department, Centre Léon Bérard, Lyon, Rhône-Alpes, France.; Campbell DJ; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.; Metzger S; Clinical Research Platform, DRCI, Centre Léon Bérard, Lyon, Rhône-Alpes, France.; Duhen T; Earle A Chiles Research Institute, Portland, Oregon, USA.; Trédan O; Medical Oncology, Centre Léon Bérard, Lyon, France.; Caux C; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France.; Ménétrier-Caux C; TERI Department, Centre de Recherche en Cancerologie de Lyon, Lyon, France christine.caux@lyon.unicancer.fr.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Quesada S; Institut régional du cancer de Montpellier - ICM (UNICANCER), département d'oncologie médicale, Montpellier, France. Electronic address: stanislas.quesada@icm.unicancer.fr.; Lebreton C; Institut Bergonié (UNICANCER), département d'oncologie médicale, Bordeaux, France; ARTiSt Lab, Inserm U1312, université de Bordeaux, Bordeaux, France.; Caux C; Centre Léon Bérard, CNRS 5286, Inserm 1052, université Claude Bernard Lyon 1, université de Lyon, centre de recherche en cancérologie de Lyon (CRCL), Équipe 'Surveillance immunitaire des tumeurs et ciblage thérapeutique', Lyon, France; Laboratoire d'immunothérapie du cancer de Lyon (LICL), Lyon, France.; Italiano A; Institut Bergonié (UNICANCER), département d'oncologie médicale, Bordeaux, France; Université de Bordeaux, faculté de médecine, Bordeaux, France; DITEP, institut Gustave Roussy - IGR (UNICANCER), Villejuif, France.; Dubois B; Centre Léon Bérard, CNRS 5286, Inserm 1052, université Claude Bernard Lyon 1, université de Lyon, centre de recherche en cancérologie de Lyon (CRCL), Équipe 'Surveillance immunitaire des tumeurs et ciblage thérapeutique', Lyon, France; Laboratoire d'immunothérapie du cancer de Lyon (LICL), Lyon, France.
Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Caux C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어